ArticleClinical and translational medicine2022

Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.

Hui Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.